|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash and due from banks | |||||||||
| Interest-bearing deposits in other banks | |||||||||
| Total cash and cash equivalents | |||||||||
| Securities available for sale, at fair value | |||||||||
| Securities held to maturity, at carrying value, net of allowance for credit losses of $64 and $128, respectively (fair value of $193,388 and $245,276, respectively) | |||||||||
| Equity securities, at fair value | |||||||||
| Restricted securities, at cost | |||||||||
| Loans held for sale | |||||||||
| Loans, net of allowance for credit losses of $4,185 and $4,096, respectively | |||||||||
| Premises and equipment, net of accumulated depreciation of $8,215 and $7,755, respectively | |||||||||
| Accrued interest receivable | |||||||||
| Other assets | |||||||||
| Total assets | |||||||||
| Liabilities and stockholders’ equity | |||||||||
| Liabilities | |||||||||
| Deposits: | |||||||||
| Noninterest-bearing | |||||||||
| Savings, interest-bearing checking and money market accounts | |||||||||
| Time, $250 and over | |||||||||
| Other time | |||||||||
| Total deposits | |||||||||
| Short-term borrowings | |||||||||
| Accrued interest payable | |||||||||
| Accrued expenses and other liabilities | |||||||||
| Total liabilities | |||||||||
| Stockholders’ equity | |||||||||
| Preferred stock: No par value, 100,000 shares authorized, no shares issued and outstanding | |||||||||
| Class A and B Common Stock | |||||||||
| Class A Common Stock | |||||||||
| Class B Common Stock | |||||||||
| Additional paid-in capital | |||||||||
| Retained earnings | |||||||||
| Accumulated other comprehensive loss | |||||||||
| Total stockholders’ equity | |||||||||
| Total liabilities and stockholders’ equity |
Loading...